Author:
Reuser Arnold,Kroos Marian
Reference168 articles.
1. Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, Mackey J, Kishnani P, Smith W, McVie-Wylie A, Sullivan JA, Hoganson GE, Phillips JA, 3rd, Schaefer GB, Charrow J, Ware RE, Bossen EH and Chen YT (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial. Genet Med, 3, 132-138.
2. Amalfitano A, McVie-Wylie AJ, Hu H, Dawson TL, Raben N, Plotz P and Chen YT (1999) Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proceedings of the National Academy of Sciences of the United States of America, 96, 8861-8866.
3. Anneser JM, Pongratz DE, Podskarbi T, Shin YS and Schoser BG (2005) Mutations in the acid alpha-glucosidase gene (M. Pompe) in a patient with an unusual phenotype. Neurology, 64, 368-70.
4. Ausems MG, ten Berg K, Sandkuijl LA, Kroos MA, Bardoel AF, Roumelioti KN, Reuser AJ, Sinke R and Wijmenga C (2001) Dutch patients with glycogen storage disease type II show common ancestry for the 525delT and del exon 18 mutations. J Med Genet, 38, 527-9.
5. Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, Sandkuijl LA, Reuser AJ and van der Ploeg AT (1999) Frequency of glycogen storage disease type II in The Netherlands: Implications for diagnosis and genetic counselling. Euro J Hum Gen, 7, 713-6.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献